Cell therapy

The research of the Cell Therapy team focuses on innovative cell therapies and ex vivo cell editing. Researchers are working on developing therapies to patients suffering from cancers. Early research on cell characterization includes traditional and ‘omics’ methodologies to support product development and the critical quality attributes definition relevant to the mode of action and safety. Therapeutic potential and modes of action are examined using in vitro methods and relevant animal models. We take pride in our process development on finding the best solution for automated, closed processes that can ensure robust and reproducible product manufacturing.

Examples of our Cell Therapy team capabilities include;
– Automated and manual cell enrichment
– Bioreactor testing for adherent and suspension cultures
– Downstream wash and formulation solutions
– Single-cell sorting in a BSL2 environment.


Accurate and advanced analytics is an essential core capability in the ATMPs area. Our Analytical team provides ‘state of the art’ analytical capabilities to support daily routine research level analytics, to develop new assay approaches, to provide technical help and training to researchers and to track the development of analytical technologies.

Examples of our analytical capabilities for cell and molecular biology applications include:
– Immunoassays: ELISAs, western blots
– BCA, picogreen, spectrophotometry
– Polymerase chain reactions: ddPCR, qPCR, PCR
– Flow cytometry analyses (+cell sorter)
– Fluorescence microscopy
– Live cell imaging
– Bioinformatics, large data analysis.